Glycated Albumin and Diabetes: Wave of the Future?

CME : 0.25 + more
Start Date :  Jan 11, 2021End Date :  Jan 11, 2022

Organized by :   Medscape, LLC

Specialties :   Endocrinology

Fees Fee :   Starting From Free

Conference Summary

Glycated Albumin and Diabetes: Wave of the Future? is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 1/11/2021
Valid for credit through: 1/11/2022

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Goal Statement:
The goal of this activity is to improve awareness of glycated albumin and its clinical importance for management of type 2 diabetes (T2D).

Upon completion of this activity, participants will:
• Have increased knowledge regarding the
○ Use of glycated albumin (GA) as a strategy for assessing intermediate glycemic control
• Have greater competence related to
○ Use of GA to inform clinical practice decisions

Credit Info

  • CME : 0.25
  • MOC : 0.25
Contact Us

Toll free Number

1(800) 826-2059


Chat Assistant

Live Chat